Tag: trading

Los Angeles, CA, July 11, 2025 (GLOBE NEWSWIRE) -- Bitcoin, the world's largest cryptocurrency, soared to a high of $118,000 during Asian trading hours on Friday, and has risen by more than 24% so far this year.

KOSICE, Slovakia, July 11, 2025 (GLOBE NEWSWIRE) -- Remittix, a rising decentralized finance (DeFi) project focused on seamless crypto-to-fiat payments, has successfully completed a comprehensive security audit conducted by Certik, a leading blockchain security firm. This achievement marks a key step toward the official launch of Remittix’s PayFi infrastructure—a next-generation payment protocol designed to streamline crypto settlements directly to bank accounts.

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Southern District of California against XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (“XPLR” or the “Company”) (NYSE: XIFR), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b 5) on behalf of all persons other than Defendants who purchased or otherwise acquired XPLR common units between September 27, 2023 and January 27, 2025, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Scott+Scott is captioned: James Alvrus v. XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP, et al., Case No. 3:25-cv-01755.

When the market no longer gives a definite answer, active value-added is the long-term solution for investors

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.

JENA, Germany, July 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it has received a written notice (the “Notice”), dated July 11, 2025, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common shares had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”).

Profusa's Common Stock is Expected to Begin Trading on Nasdaq on Monday, July 14, 2025 Under the Ticker "PFSA"

Blockchain cloud mining helps cryptocurrency enthusiasts achieve financial freedom